月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！
Gland Surgery （Gland Surg; GS，Print ISSN 2227-684X; Online ISSN 2227-8575）于2012年5月推出，于2014年6月在PubMed / PubMed Central 收录，2018年12月收录 SCIE，是一本开放获取，同行评审的期刊重点关注腺体手术近期的科学进展。2018年GS的影响因子为1.922。作为双月刊出版的期刊，它旨在提供有关腺体疾病的诊断，预防和治疗的前沿研究结果和实用信息，如乳腺癌，甲状腺癌，肾上腺癌，胰腺手术和其他相关领域。致力于理解和治疗腺体疾病，这个多学科期刊发表文章，描述来自一系列领域的腺体疾病的基础，转化和临床研究，如生物标志物，影像学，病理学，生物学和介入放射学等。读者可望获得新的了解腺体疾病的诊断，治疗方法和预后。
http://gs.amegroups.com/login?source=%2Fauthor%2Fsubmit
Gland Surgery (Gland Surg; GS, Print ISSN 2227-684X; Online ISSN 2227-8575), launched in May 2012, indexed in PubMed/PubMed Central in June 2014 and SCIE in December 2018, is an open access, peer-reviewed journal focused on recent scientific advances in gland surgery. The 2018 Impact Factor for GS is 1.922.As a bimonthly published journal, it aims at providing cutting-edge findings and practical information on diagnosis, prevention, and treatment of gland diseases, such as breast, thyroid, adrenal, pancreas surgery and other related fields. Dedicated to the understanding and treatment of gland diseases, this multidisciplinary periodical publishes articles that describe basic, translational and clinical research of gland disease from a range of fields as biomarkers, imaging, pathology, biology and interventional radiology etc. Readers can expect to gain new insights into diagnosis, therapeutic approaches and prognosis of gland diseases.
